Search Results - robbert+creton

1 Results

Sort By:

New use of CsA-type drugs for the prevention and treatment of neurodegenerative disorders, including Alzheimer’s disease

Novel Method Repurposes CsA-Type Compounds to Treat Neurodegenerative Disease Overview Alzheimer’s disease remains a challenging disorder for drug development, with many candidate drugs failing clinical trials. Our novel method repurposes camphorsulfonic acid (CsA)-type compounds to treat early-stage Alzheimer’s disease, as well as...

Published: 4/29/2022 | Inventor(s): Robbert Creton

Keywords(s):

Category(s): Therapeutics, Neurodegenerative Disease